1053 related articles for article (PubMed ID: 33618678)
1. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
2. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K; Kim H; Bonomo E; Dolma R
PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
[TBL] [Abstract][Full Text] [Related]
7. Features of severe COVID-19: A systematic review and meta-analysis.
Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
[TBL] [Abstract][Full Text] [Related]
8. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
Shin EK; Choi HY; Hayes N
Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.
Qiu P; Zhou Y; Wang F; Wang H; Zhang M; Pan X; Zhao Q; Liu J
Aging Clin Exp Res; 2020 Sep; 32(9):1869-1878. PubMed ID: 32734576
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.
Zhao J; Li X; Gao Y; Huang W
Int J Med Sci; 2020; 17(12):1744-1750. PubMed ID: 32714077
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
He Y; Xie M; Zhao J; Liu X
Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
Islam MZ; Riaz BK; Islam ANMS; Khanam F; Akhter J; Choudhury R; Farhana N; Jahan NA; Uddin MJ; Efa SS
Epidemiol Infect; 2020 Oct; 148():e263. PubMed ID: 33115547
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
[TBL] [Abstract][Full Text] [Related]
15. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis.
Honardoost M; Janani L; Aghili R; Emami Z; Khamseh ME
Cerebrovasc Dis; 2021; 50(2):132-140. PubMed ID: 33530081
[TBL] [Abstract][Full Text] [Related]
16. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis.
Cheng S; Zhao Y; Wang F; Chen Y; Kaminga AC; Xu H
Medicine (Baltimore); 2021 Mar; 100(12):e24971. PubMed ID: 33761654
[TBL] [Abstract][Full Text] [Related]
18. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
[TBL] [Abstract][Full Text] [Related]
20. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
